Urinary Tract Infections (Vaccines)

Early Results Suggest Vaginal Immunization May Delay Recurrent UTIs

Published in Vaccine Weekly, June 17th, 1996

Early results of a Phase II clinical trial of vaginal immunization against recurrent urinary tract infections (RUTI) yield promising results.

Despite no identifiable anatomic abnormalities, many women remain highly susceptible to RUTI. Because mucosal immunity can boost host defenses against infection, David T. Uehling et al. attempted to boost mucosal immunity against RUTI in the bladder through vaginal immunization.

Uehling presented results of this research to the 91st Annual Meeting of the American Urological Association, held May 4-9, 1996, in Orlando, Florida (Astract: "Early Results of Phase II Clinical Trial of Vaginal Immunization for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1996-06-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry